Volume 22, Number 3—March 2016
Dispatch
Treatment of Mycobacterium abscessus Infection
Shannon A. Novosad
, Susan E. Beekmann, Philip M. Polgreen, Kate Mackey, Kevin L. Winthrop, and M. abscessus Study Team
, Susan E. Beekmann, Philip M. Polgreen, Kate Mackey, Kevin L. Winthrop, and M. abscessus Study Team
Table 2
Side effects associated with antimicrobial drug therapy for Mycoobacterium abscessus infection, March–December 2013*
| Side effect | No. (%) |
|---|---|
| Gastrointestinal† | 23 (41.8) |
| Skin changes‡ | 11 (20.0) |
| Renal insufficiency | 9 (16.4) |
| Hearing loss | 7 (12.7) |
| Tinnitus | 6 (10.9) |
| Loss of balance | 4 (7.3) |
| Transaminitis | 4 (7.3) |
| Shortness of breath or airway irritation | 3 (5.5) |
| Neutropenia or thrombocytopenia | 2 (3.6) |
| Other§ | 5 (9.1) |
*Data for 55 patients; some patients reported the same adverse event >1 time and attributed it to different medications. Here, each adverse event is reported only 1 time.
†Nausea/vomiting, abdominal pain, diarrhea.
‡Rash, pruritis, discoloration.
§Anxiety, failure to thrive, fatigue, oral and genitourinary candidiasis.
1Members of the study team are listed at the end of this article.
Page created: February 18, 2016
Page updated: February 18, 2016
Page reviewed: February 18, 2016
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.